Enhancing Efficacy of TCR-engineered CD4 + T Cells Via Coexpression of CD8&#945;.

Anderson, Victoria E; Brilha, Sara S; Weber, Anika M; Pachnio, Annette; Wiedermann, Guy E; Dauleh, Sumaya; Ahmed, Tina; Pope, George R; Quinn, Laura L; Docta, Roslin Y; Quattrini, Adriano; Masters, Siobhan; Cartwright, Neil; Viswanathan, Preetha; Melchiori, Luca; Rice, Louise V; Sevko, Alexandra; Gueguen, Claire; Saini, Manoj; Tavano, Barbara; Abbott, Rachel J M; Silk, Jonathan D; Laugel, Bruno; Sanderson, Joseph P; Gerry, Andrew B

Enhancing Efficacy of TCR-engineered CD4 + T Cells Via Coexpression of CD8α.

Anderson, Victoria E; Brilha, Sara S; Weber, Anika M; Pachnio, Annette; Wiedermann, Guy E; Dauleh, Sumaya; Ahmed, Tina; Pope, George R; Quinn, Laura L; Docta, Roslin Y; Quattrini, Adriano; Masters, Siobhan; Cartwright, Neil; Viswanathan, Preetha; Melchiori, Luca; Rice, Louise V; Sevko, Alexandra; Gueguen, Claire; Saini, Manoj; Tavano, Barbara; Abbott, Rachel J M; Silk, Jonathan D; Laugel, Bruno; Sanderson, Joseph P; Gerry, Andrew B.

Affiliation

Anderson VE; Adaptimmune, Abingdon, Oxfordshire, UK.

J Immunother ; 46(4): 132-144, 2023 05 01.

Article in En | MEDLINE | ID: mdl-36826388

Subject(s)

Antineoplastic Agents; CD40 Ligand; Humans; CD4-Positive T-Lymphocytes; T-Lymphocytes, Helper-Inducer; Receptors, Antigen, T-Cell/metabolism

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: CD40 Ligand / Antineoplastic Agents Limits: Humans Language: En Journal: J Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 2023 Type: Article Affiliation country: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google